The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations With its debut registration of Sugammadex in Philippines, Venus Remedies strengthens its foothold in the ASEAN market Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading Indian manufacturer